Average Co-Inventor Count = 10.83
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (14 from 3,923 patents)
14 patents:
1. 12071441 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
2. 11912715 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
3. 11629149 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
4. 11453677 - Tricyclic compounds useful to treat orthomyxovirus infections
5. 11098051 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
6. 10858366 - Tricyclic compounds useful to treat orthomyxovirus infections
7. 10709712 - Biaryl amide compounds as kinase inhibitors
8. 10392404 - Compounds and compositions as kinase inhibitors
9. 10245267 - Biaryl amide compounds as kinase inhibitors
10. 10167279 - Compounds and compositions as RAF kinase inhibitors
11. 10160764 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
12. 9694016 - Biaryl amide compounds as kinase inhibitors
13. 8778951 - Heteroaryl compounds and their uses
14. 8415381 - Heteroaryl compounds and their uses